Skip to main content
. 2020 Apr 13;24(4):216–227. doi: 10.1089/omi.2019.0191

FIG. 4.

FIG. 4.

Validation of selected candidate phosphopeptides by PRM assays. (A) Workflow of the validation approach that was carried out by using PRM assays for a subset of altered phosphosites. (B) MAPT. (C) MARCKS. The peptide sequences and p-values are shown in each case. MARCKS, myristoylated alanine-rich protein kinase C substrate; PRM, parallel reaction monitoring.